{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:26:05Z","timestamp":1793316365367,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jconrel.2022.12.052","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T18:23:39Z","timestamp":1672856619000},"page":"57-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Triple functional mild photothermal improves gene editing of PD-L1 for enhanced antitumor immunity"],"prefix":"10.1016","volume":"354","author":[{"given":"Yi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.12.052_bb0005","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3747\/co.27.5223","article-title":"A review of cancer immunotherapy: from the past, to the present, to the future","volume":"27","author":"Esfahani","year":"2020","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jconrel.2021.06.025","article-title":"Cancer immunotherapy from biology to nanomedicine","volume":"336","author":"Abdelbaky","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.12.052_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12531","article-title":"Introduction to checkpoint inhibitors and cancer immunotherapy","volume":"276","author":"Sharpe","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0020","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2020.07.004","article-title":"Clinical challenges of immune checkpoint inhibitors","volume":"38","author":"de Miguel","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2022.12.052_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JCO.19.01712","article-title":"Assessment of adverse events and their ability to discriminate response to anti-PD-1\/PD-L1 antibody immunotherapy","volume":"38","author":"McLeod","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0030","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2022.12.052_bb0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nbt.2842","article-title":"CRISPR-Cas systems for editing, regulating and targeting genomes","volume":"32","author":"Sander","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2019.11.005","article-title":"Rational designs of in vivo CRISPR-Cas delivery systems","volume":"168","author":"Xu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.addr.2020.03.001","article-title":"Synthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing","volume":"168","author":"Tang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0050","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1021\/cr400532z","article-title":"Functional nanomaterials for phototherapies of cancer","volume":"114","author":"Cheng","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0055","doi-asserted-by":"crossref","first-page":"1906623","DOI":"10.1002\/adfm.201906623","article-title":"Combination of bacterial-photothermal therapy with an anti-PD-1 peptide depot for enhanced immunity against advanced cancer","volume":"30","author":"Chen","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0060","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.1002\/adma.201402996","article-title":"Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis","volume":"26","author":"Wang","year":"2014","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0065","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41467-018-03473-9","article-title":"Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer","volume":"9","author":"Nam","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0070","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/anie.201407629","article-title":"Synthesis of nitrogendoped mesoporous carbon spheres with extra-large pores through assembly of diblock copolymer micelles","volume":"54","author":"Tang","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0075","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1039\/C8TB02310G","article-title":"Polydopamine nanostructures as biomaterials for medical applications","volume":"6","author":"Kwon","year":"2018","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2022.12.052_bb0080","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.apsb.2021.03.023","article-title":"Magnetic systems for cancer immunotherapy","volume":"11","author":"Day","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.12.052_bb0085","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.7150\/thno.42564","article-title":"Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics","volume":"10","author":"Zhao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2022.12.052_bb0090","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1021\/acsnano.9b04436","article-title":"Versatile polydopamine platforms: synthesis and promising applications for surface modification and advanced nanomedicine","volume":"13","author":"Cheng","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.12.052_bb0095","series-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.jconrel.2022.12.052_bb0100","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2022.12.052_bb0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0006-291X(63)90163-3","article-title":"A simple method for the quantitative isolation of undegraded high molecular weight ribonucleic acid","volume":"13","author":"Barlow","year":"1963","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119847","article-title":"Mesoporous polydopamine with built-in plasmonic core: traceable and NIR triggered delivery of functional proteins","volume":"238","author":"Wu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.12.052_bb0115","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ymthe.2018.02.023","article-title":"Efficient in vivo liver-directed gene editing using CRISPR\/Cas9","volume":"26","author":"Singh","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2022.12.052_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01408-4","article-title":"A thermostable Cas9 with increased lifetime in human plasma","volume":"8","author":"Harrington","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0130","article-title":"Reprogramming the tumor microenvironment through second-near-infrared-window photothermal genome editing of PD-L1 mediated by supramolecular gold nanorods for enhanced cancer immunotherapy","volume":"33","author":"Tang","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1432-1033.1991.tb16337.x","article-title":"The molecular action of tumor-necrosis-factor-alpha","volume":"202","author":"Camussi","year":"1991","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0140","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.4049\/jimmunol.157.4.1350","article-title":"A direct role for IFN-gamma in regulation of Th1 cell development","volume":"157","author":"Bradley","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0145","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0150","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3390\/cancers10100366","article-title":"Bipolar tumor-associated macrophages in ovarian cancer as targets for therapy","volume":"10","author":"Gupta","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2022.12.052_bb0155","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","article-title":"Distinct role of macrophages in different tumor microenvironments","volume":"66","author":"Lewis","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0160","doi-asserted-by":"crossref","first-page":"2101155","DOI":"10.1002\/smll.202101155","article-title":"Controlled CRISPR-Cas9 ribonucleoprotein delivery for sensitized photothermal therapy","volume":"17","author":"Chen","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2022.12.052_bb0165","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1073\/pnas.1912220117","article-title":"Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing","volume":"117","author":"Chen","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.jconrel.2022.12.052_bb0170","doi-asserted-by":"crossref","first-page":"18197","DOI":"10.1002\/anie.201909264","article-title":"A photolabile semiconducting polymer nanotransducer for nearinfrared regulation of CRISPR\/Cas9 gene editing","volume":"58","author":"Lyu","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0175","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1021\/acs.molpharmaceut.6b00839","article-title":"Iron oxide nanoparticle based contrast agents for magnetic resonance imaging","volume":"14","author":"Shen","year":"2017","journal-title":"Mol. Phamac."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0180","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1093\/nar\/gku402","article-title":"CRISPR\/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences","volume":"42","author":"Lin","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0185","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0190","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/1061186X.2018.1440400","article-title":"Development of small-molecule immune checkpoint inhibitors of PD-1\/PD-L1 as a new therapeutic strategy for tumour immunotherapy","volume":"27","author":"Li","year":"2018","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0195","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.humpath.2015.09.003","article-title":"PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas","volume":"47","author":"Cimino-Mathews","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0200","author":"Co"},{"key":"10.1016\/j.jconrel.2022.12.052_bb0205","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fphar.2017.00561","article-title":"PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome","volume":"8","author":"Alsaab","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0210","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fimmu.2019.02022","article-title":"PD-L1 distribution and perspective for cancer immunotherapy-blockade, knockdown, or inhibition","volume":"10","author":"Wu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2022.12.052_bb0215","doi-asserted-by":"crossref","first-page":"2002504","DOI":"10.1002\/advs.202002504","article-title":"Solutions to the drawbacks of photothermal and photodynamic cancer therapy","volume":"8","author":"Deng","year":"2021","journal-title":"Adv. Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922008665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922008665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:32:39Z","timestamp":1759163559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922008665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":43,"alternative-id":["S0168365922008665"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.052","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triple functional mild photothermal improves gene editing of PD-L1 for enhanced antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}